Explore the application of the Genexus turnkey NGS platform for molecular profiling of non-small cell lung cancer (NSCLC) samples in this informative 19-minute webinar presented by Dr. Brendan Pang, a Consultant Pathologist and Medical/Laboratory Director at Angsana Molecular and Diagnostics and Parkway Laboratory Services Ltd. Gain insights into the latest advancements in next-generation sequencing (NGS) technology and its role in enhancing the molecular characterization of NSCLC. Learn how this innovative platform streamlines the process of genetic profiling, potentially improving diagnostic accuracy and treatment decision-making for NSCLC patients. Discover the potential impact of this technology on personalized medicine approaches in lung cancer management.
Utilization of the Genexus Turnkey NGS Platform for Molecular Profiling of NSCLC Samples
Overview
Syllabus
Utilization of the Genexus turnkey NGS platform for molecular profiling of NSCLC samples
Taught by
Labroots
Related Courses
-
NGS in the Clinical Laboratory - Experiences of the Holycross Cancer Center with One-Day NGS
-
Development of a Novel Targeted NGS Panel for Analysis of DNA Methylation Biomarkers in Lung Cancer
-
Quest Diagnostics with Covaris Launches Automated NGS Platform - Optimizing Workflows to Maximize Lab Economics
-
Building a Scalable Clinical Genomics Program - Spring 2021
-
The Evolving Landscape of Lung Cancer Treatment
-
Comprehensive Methylation Profiling from Low-Input Samples Using the xGen Methyl-Sequencing Workflow
